Remove Data Remove Patients Remove Treatment
article thumbnail

Study: Cannabis Associated with Reduced Opioid Use, Prolonged Benefits in Pain Patients

NORML

The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine. ’

Patients 355
article thumbnail

Study: Cannabis Safe and Effective in Fibromyalgia Patients

NORML

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.

Patients 279
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CBD Topical Medicine: What Does the Science Say?

Project CBD

Of course, what matters most to patients and clinicians is whether topical and transdermal cannabinoids really work. Ultimately, they concluded that the available data on pain and other outcomes was unreliable, with a high risk of bias. They also employ special delivery systems like adhesive patches, hydrogels, and nano-emulsions.

Topical 179
article thumbnail

CDC Seeks Public Comments Regarding Chronic Pain Management

NORML

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

article thumbnail

The Changing Landscape of Medical Marijuana in Massachusetts: What Patients Should Know

Canna Care Docs

The Changing Landscape of Me dical Marijuana in Massachusetts: What Patients Should Know The Massachusetts medical marijuana program has been a cornerstone of cannabis access since its inception in 2012. MPAA) the states leading voice for patient rights and cannabis policy reform. decrease from peak enrollment.

article thumbnail

A NORML Reminder: Beware of COVID-19 Cure All Claims

NORML

Yet despite these and other claims , including those spreading on social media , there is as of yet no substantiated clinical data supporting either the prophylactic or therapeutic use of cannabis products in the treatment of COVID-19.

CBD 352